G. Hafiz

发表

Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab

P. Campochiaro, Q. Nguyen, R. Channa, 2014, Eye.

Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.

P. Campochiaro, T. Ciulla, David M. Brown, 2010, Ophthalmology.

Increased Frequency of Topical Steroids Provides Benefit in Patients With Recalcitrant Postsurgical Macular Edema.

P. Campochiaro, I. Zimmer-Galler, T. Y. A. Liu, 2017, American journal of ophthalmology.

Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial.

P. Campochiaro, H. Ying, I. Zimmer-Galler, 2015, Ophthalmology (Rochester, Minn.).

Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.

P. Campochiaro, H. Ying, I. Zimmer-Galler, 2010, Ophthalmology.

Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion.

P. Campochiaro, H. Ying, D. Barañano, 2013, American journal of ophthalmology.

A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration.

P. Campochiaro, J. Cedarbaum, Q. Nguyen, 2006, Ophthalmology.

A RANDOMIZED, DOUBLE-MASKED CONTROLLED CLINICAL TRIAL OF SANDOSTATIN LONG-ACTING RELEASE DEPOT IN PATIENTS WITH POSTSURGICAL CYSTOID MACULAR EDEMA

J. Haller, Q. Nguyen, D. Do, 2010, Retina.

Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants.

P. Campochiaro, Q. Nguyen, T. Ciulla, 2013, Ophthalmology.

Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study.

Ian C. Han, P. Campochiaro, H. Ying, 2015, American journal of ophthalmology.

Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate

P. Campochiaro, J. Handa, Q. Nguyen, 2013, BMC Pharmacology and Toxicology.

Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.

P. Campochiaro, I. Zimmer-Galler, J. Haller, 2008, American journal of ophthalmology.

Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein Occlusion.

Christopher J Brady, Ian C. Han, P. Campochiaro, 2016, Ophthalmology.

Topical mecamylamine for diabetic macular edema.

P. Campochiaro, I. Zimmer-Galler, J. Cooke, 2010, American journal of ophthalmology.

Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.

Sharon D. Solomon, P. Campochiaro, H. Ying, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Cataract and barriers to cataract surgery in a US Hispanic population: Proyecto VER.

R. Klein, B. Munoz, S. West, 2005, Archives of ophthalmology.

Monitoring ocular drug therapy by analysis of aqueous samples.

P. Campochiaro, Q. Nguyen, Roman G. Rubio, 2009, Ophthalmology.

Interleukin‐18 Has Antipermeablity and Antiangiogenic Activities in the Eye: Reciprocal Suppression With VEGF

P. Campochiaro, J. Arron, T. Iwase, 2014, Journal of cellular physiology.

Is There Excess Oxidative Stress and Damage in Eyes of Patients with Retinitis Pigmentosa?

P. Campochiaro, Y. Wolfson, H. Scholl, 2015, Antioxidants & redox signaling.

URINARY METABOLOMICS OF CENTRAL SEROUS CHORIORETINOPATHY

K. Freund, J. Handa, C. Meyerle, 2022, Retina.

Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.

P. Campochiaro, Q. Nguyen, R. Channa, 2013, JAMA ophthalmology.

Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex Trial.

Christopher J Brady, Ian C. Han, P. Campochiaro, 2016, American journal of ophthalmology.

Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema.

P. Campochiaro, I. Zimmer-Galler, S. Solomon, 2019, American journal of ophthalmology.

Locus Level Changes in Macular Sensitivity in Patients with Retinitis Pigmentosa Treated with Oral N-acetylcysteine.

P. Campochiaro, X. Kong, G. Hafiz, 2020, American journal of ophthalmology.

Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase 1 trial.

P. Campochiaro, Mandeep S. Singh, X. Kong, 2019, The Journal of clinical investigation.